TACKLE study List of articles

ELIQUENT Japan > TACKLE study

2025.07.10

Medicine,capsules,isolated,from,the,white,background.,3d,rendering

Chugai Files for Tumor-Agnostic Indication of Alecensa in ALK Fusion-Positive Solid Tumors

Introduction to Alecensa Indication Expansion  According to a news article (中外製薬　アレセンサで小児含むALK陽性固形がんの適応拡大 […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570